UnitedHealth Group’s Optum Rx will remove reauthorization requirements for more than 60 chronic disease medications on July 1.
The cuts are in addition to about 80 reauthorizations Optum Rx eliminated in March, which the company said will increase medication accessibility and improve health outcomes.
The 60-some medications include treatments for behavioral health, dry eye disease, high cholesterol, HIV and hypertension, according to a June 30 news release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.